CLS Holdings (LSE:CLI) Research & Development: £0.0 Mil (TTM As of Dec. 2025)


LSE:CLI CLS Holdings PLC LSE:CLI
40 GF Score
Price £0.49
GF Value £0.81
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is CLS Holdings Research & Development?

CLS Holdings LSE:CLI +1.15% 40 Research & Development is £0.0 Mil as of Dec. 2025. GuruFocus rates LSE:CLI with a GF Score™ of 40/100 and a GF Value™ of £0.81 (Possible Value Trap). The stock has 7 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. CLS Holdings's Research & Development for the six months ended in Dec. 2025 was £0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was £0.0 Mil.


CLS Holdings  (LSE:CLI) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


CLS Holdings Research & Development Related Terms


CLS Holdings Research & Development Historical Data

* Premium members only.

The historical data trend for CLS Holdings's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CLS Holdings Research & Development Chart

CLS Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

CLS Holdings Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
LSE:CLI
40GF Score
CLS Holdings PLC LSE:CLI
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CLS Holdings Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was £0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of £0.0 Mil mean?
CLS Holdings (LSE:CLI) has a Research & Development of £0.0 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on CLS Holdings and its competitors.
Is CLS Holdings' Research & Development too high?
CLS Holdings' current Research & Development is £0.0 Mil. Overall, CLS Holdings has a GF Score™ of 40/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does CLS Holdings' Research & Development compare to BXP and ARE?
CLS Holdings' Research & Development of £0.0 Mil can be compared against companies in the REITs industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a REITs company?
A good Research & Development depends on the REITs industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on CLS Holdings and its competitors. CLS Holdings's current Research & Development is £0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CLS Holdings stock overvalued right now?
Based on GuruFocus' analysis, CLS Holdings (LSE:CLI) is currently considered Possible Value Trap. The stock's GF Value™ is £0.81, compared to a current price of £0.49 — trading 40.1% below its estimated fair value. The current Research & Development is £0.0 Mil. CLS Holdings' overall GF Score™ is 40/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For CLS Holdings (LSE:CLI), the current Research & Development is £0.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is CLS Holdings (LSE:CLI) Overvalued in 2026?

Based on GuruFocus' analysis, CLS Holdings stock appears to be undervalued. The current stock price of £0.49 is trading 40.1% below its estimated GF Value™ of £0.81. GuruFocus considers CLS Holdings to be Possible Value Trap.

Key valuation signals for LSE:CLI:

  • Research & Development: £0.0 Mil
  • GF Value™: £0.81 vs. price of £0.49 (40.1% below fair value)
  • GF Score™: 40/100 with 7 warning signs

No single metric tells the full story. See the LSE:CLI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


CLS Holdings Business Description

Industry Real EstateREITs
Other Exchanges CLIl:UK838:Germany
Address 16 Tinworth Street, London, GBR, SE11 5AL
CLS Holdings PLC is a commercial property investment firm focused on office space. The company has two operating segments: Investment Property and Other Investments. The Investment Property segment includes properties in the United Kingdom, Germany, and France, with over half of its assets located in the United Kingdom. Other Investments comprise the hotel at Spring Mews and various small corporate holdings. The company invests in non-central locations that offer efficient access to transportation and are situated in large cities. It generates the majority of its revenue from rental income.
40GF Score

Get the complete analysis for LSE:CLI

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£0.49
Price
£0.81
GF Value